WEBINAR: Protections Against Employment, Housing and Health Care Discrimination for People Living with or at High Risk of Acquiring HIV

Protections Against Employment, Housing, and Health Care Discrimination for People Living with or at High Risk of Acquiring HIV

Release date: March 15, 2022

Expiration date: March 15, 2023

Estimated time to complete activity: 0.75 hours

Jointly provided by Postgraduate Institute for Medicine and American Academy of HIV Medicine.

This activity is supported by an independent educational grant from Gilead Sciences, Janssen Therapeutics, and ViiV Healthcare.

square logo

Target Audience
This activity has been designed to meet the educational needs of physicians, physician assistants, nurse practitioners, pharmacists, and registered nurses; other healthcare providers, such as nutritionists, social workers, and case managers are also encouraged to attend.

Educational Objectives
As a result of participating in this activity, participants should be able to:
  • Discuss the legal framework that applies to people living with HIV as they face discrimination in employment, housing and health care
  • Delineate between the federal legislation that provides protection for disability, sex and race
  • Identify cases where patients may have experienced discrimination and how to provide assistance

Ronda B. Goldfein, Esq.
Executive Director, AIDS Law Project of Pennsylvania

Adrian Lowe, Esq.
Senior Staff Attorney, AIDS Law Project of Pennsylvania

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and The American Academy of HIV Medicine. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact house (0.75 APRN credit hours).

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number JA4008162-9999-22-095-L02-P)

Type of Activity: Knowledge

Include minimum hardware, software, internet connectivity and connection speed requirements for accessing the internet-based activity.

Fee Information: There is no fee for this educational activity.

Method of Participation and Request for Credit

In order to obtain your CE certificate, please follow the steps below at the conclusion of the activity:

  • Go to cmeuniversity.com
  • Login or Create a New Account (will take less than 1 minute)
    1. If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forgot my Username or Password link to have your Username and Password sent to you via email
    2. After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
  • Type in 16797 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter
  • Click on the activity title when it appears
  • Choose the type of credit you desire
  • Complete the Post-test with a passing score of 75% or better
  • Complete the online Evaluation
  • Receive an immediate CE Certificate to download and/or print for your files

Media: Internet

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.  The planners of this activity do not recommend the use of any agent outside of the labeled indications.  The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

The planners and their spouses/partners wish to disclose they have no financial interests or other relationships with any ACCME-defined ineligible companies.

Ronda Goldfein has nothing to disclose.
Adrian Lowe has nothing to disclose.

Hardware and Software Requirements
This program requires the use of an internet-connected computer or device and a modern web browser capable of streaming video.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

If you have questions regarding the certification of this activity, please contact PIM via email at inquiries@pimed.com.